ethylphenidate
Sign in to saveAlso known as EPH
Ethylphenidate (EPH) is a central nervous system (CNS) stimulant and a close analog of methylphenidate.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 432850456
- Drug.IUPAC_name
- (RS)-Ethyl 2-phenyl-2-piperidin-2-ylacetate
- Drug.image
- Ethylphenidate.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 225px
- Drug.image2
- Ethylphenidate-3D-ball-model.png
- Drug.image_class2
- bg-transparent
- Drug.legal_AU
- S8 (Controlled Drug)
- Drug.legal_BR
- F2
- Drug.legal_CA
- Schedule 3
- Drug.legal_UK
- Class B
- Drug.legal_UK_comment
- Temporary Class Drug
- Drug.legal_DE
- Anlage II
- Drug.legal_UN
- P II
- Drug.routes_of_administration
- By mouth, insufflation, inhalation, sublingual, rectal, intramuscular, intravenous
- Drug.bioavailability
- Variable
via Wikipedia infobox
Research
60 papers- Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.Journal of pharmaceutical sciences · 2014
- Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.European journal of clinical pharmacology · 2015
- Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects.European journal of drug metabolism and pharmacokinetics · 2017
- Seven fatalities associated with ethylphenidate.Forensic science international · 2016
- L- and D-threo ethylphenidate concentrations, pharmacokinetics, and pharmacodynamics in horses.Drug testing and analysis · 2018
via PubMed
~6 min read
Encyclopedic overview
6 sectionsContents
- Pharmacology
- Pharmacokinetics
- Pharmacodynamics
- Legality
- See also
- References
Ethylphenidate (EPH) is a central nervous system (CNS) stimulant and a close analog of methylphenidate.
Ethylphenidate acts as a norepinephrine–dopamine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain, by binding to, and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.
Excerpted from Wikipedia’s “ethylphenidate” article, available under the CC BY-SA 4.0 licence.